FR2838057B1 - Nouvelle association d'un antithrombotique et d'aspirine - Google Patents

Nouvelle association d'un antithrombotique et d'aspirine

Info

Publication number
FR2838057B1
FR2838057B1 FR0204222A FR0204222A FR2838057B1 FR 2838057 B1 FR2838057 B1 FR 2838057B1 FR 0204222 A FR0204222 A FR 0204222A FR 0204222 A FR0204222 A FR 0204222A FR 2838057 B1 FR2838057 B1 FR 2838057B1
Authority
FR
France
Prior art keywords
antithrombotics
aspirin
new association
association
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0204222A
Other languages
English (en)
French (fr)
Other versions
FR2838057A1 (fr
Inventor
Tony Verbeuren
Vieille Gilbert La
Bernard Cimetiere
Marie Odile Vallez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0204222A priority Critical patent/FR2838057B1/fr
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to EA200401293A priority patent/EA006978B1/ru
Priority to PT03745819T priority patent/PT1496884E/pt
Priority to US10/509,605 priority patent/US7618955B2/en
Priority to AU2003246774A priority patent/AU2003246774B2/en
Priority to ES03745819T priority patent/ES2264533T3/es
Priority to HK05108135.4A priority patent/HK1076034B/xx
Priority to DK03745819T priority patent/DK1496884T3/da
Priority to MXPA04009760A priority patent/MXPA04009760A/es
Priority to JP2003581765A priority patent/JP4065853B2/ja
Priority to KR1020047015845A priority patent/KR100645143B1/ko
Priority to UA20041109009A priority patent/UA79457C2/uk
Priority to BR0309019-1A priority patent/BR0309019A/pt
Priority to PL03371620A priority patent/PL371620A1/xx
Priority to GEAP8486A priority patent/GEP20074101B/en
Priority to CNB038078619A priority patent/CN1297265C/zh
Priority to CA002480697A priority patent/CA2480697A1/fr
Priority to ARP030101180A priority patent/AR039253A1/es
Priority to AT03745819T priority patent/ATE329591T1/de
Priority to PCT/FR2003/001054 priority patent/WO2003084525A1/fr
Priority to DE60306133T priority patent/DE60306133T2/de
Priority to SI200330326T priority patent/SI1496884T1/sl
Priority to NZ535430A priority patent/NZ535430A/en
Priority to EP03745819A priority patent/EP1496884B1/fr
Publication of FR2838057A1 publication Critical patent/FR2838057A1/fr
Priority to ZA200407593A priority patent/ZA200407593B/xx
Priority to NO20044700A priority patent/NO20044700L/no
Priority to MA27925A priority patent/MA27114A1/fr
Application granted granted Critical
Publication of FR2838057B1 publication Critical patent/FR2838057B1/fr
Priority to CY20061101027T priority patent/CY1105106T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0204222A 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine Expired - Fee Related FR2838057B1 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
CNB038078619A CN1297265C (zh) 2002-04-05 2003-04-04 抗血栓形成药与阿司匹林的新组合及其在制备用于治疗动脉粥样硬化血栓形成性疾病的药物中的用途
US10/509,605 US7618955B2 (en) 2002-04-05 2003-04-04 Association of an antithrombotic and aspirin
AU2003246774A AU2003246774B2 (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
ES03745819T ES2264533T3 (es) 2002-04-05 2003-04-04 Asociacion de un antitrombotico y de aspirina y su utilizacion para el tratamiento de enfermedades aterotromboticas.
HK05108135.4A HK1076034B (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases
DK03745819T DK1496884T3 (da) 2002-04-05 2003-04-04 Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme
MXPA04009760A MXPA04009760A (es) 2002-04-05 2003-04-04 Nueva asociacion de un agente antitrombotico con aspirina y su uso para tratamiento de enfermedades aterotromboticas.
ARP030101180A AR039253A1 (es) 2002-04-05 2003-04-04 Asociacion de un antitrombotico y de aspirina
KR1020047015845A KR100645143B1 (ko) 2002-04-05 2003-04-04 항혈전제와 아스피린의 결합체 및 이의 죽상혈전성 질환을치료하기 위한 용도
UA20041109009A UA79457C2 (en) 2002-04-05 2003-04-04 Association of antithrombotic agent with aspirin and pharmaceutical composition for treating atherothrombotic diseases
BR0309019-1A BR0309019A (pt) 2002-04-05 2003-04-04 Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas
PL03371620A PL371620A1 (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
GEAP8486A GEP20074101B (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
EA200401293A EA006978B1 (ru) 2002-04-05 2003-04-04 Новое сочетание антитромботического агента и аспирина
AT03745819T ATE329591T1 (de) 2002-04-05 2003-04-04 Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen
JP2003581765A JP4065853B2 (ja) 2002-04-05 2003-04-04 抗血栓剤とアスピリンとの新規な組み合わせ及びアテローム血栓性疾患を処置するためのその使用
PT03745819T PT1496884E (pt) 2002-04-05 2003-04-04 Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine
DE60306133T DE60306133T2 (de) 2002-04-05 2003-04-04 Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen
SI200330326T SI1496884T1 (sl) 2002-04-05 2003-04-04 Kombinacija antitrombotika in aspirina in njena uporaba za zdravljenje aterotromboticnih bolezni
NZ535430A NZ535430A (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
EP03745819A EP1496884B1 (fr) 2002-04-05 2003-04-04 Association d'un antithrombotique et d'aspirin et son utilisation pour le traitement des maladies thrombotiques atherosclereuses
CA002480697A CA2480697A1 (fr) 2002-04-05 2003-04-04 Association d'un antithrombotique et d'aspirine
ZA200407593A ZA200407593B (en) 2002-04-05 2004-09-21 Novel association of an antithrombonic agent with asperin and use thereof for treating atherothrombonic diseases
NO20044700A NO20044700L (no) 2002-04-05 2004-10-29 Ny assoiasjon av et antitrombotisk middel og aspirin
MA27925A MA27114A1 (fr) 2002-04-05 2004-11-03 Nouvelle association d'un antithrombotique et d'aspirine
CY20061101027T CY1105106T1 (el) 2002-04-05 2006-07-24 Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Publications (2)

Publication Number Publication Date
FR2838057A1 FR2838057A1 (fr) 2003-10-10
FR2838057B1 true FR2838057B1 (fr) 2005-07-08

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0204222A Expired - Fee Related FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Country Status (26)

Country Link
US (1) US7618955B2 (enExample)
EP (1) EP1496884B1 (enExample)
JP (1) JP4065853B2 (enExample)
KR (1) KR100645143B1 (enExample)
CN (1) CN1297265C (enExample)
AR (1) AR039253A1 (enExample)
AT (1) ATE329591T1 (enExample)
AU (1) AU2003246774B2 (enExample)
BR (1) BR0309019A (enExample)
CA (1) CA2480697A1 (enExample)
CY (1) CY1105106T1 (enExample)
DE (1) DE60306133T2 (enExample)
DK (1) DK1496884T3 (enExample)
EA (1) EA006978B1 (enExample)
ES (1) ES2264533T3 (enExample)
FR (1) FR2838057B1 (enExample)
GE (1) GEP20074101B (enExample)
MA (1) MA27114A1 (enExample)
MX (1) MXPA04009760A (enExample)
NO (1) NO20044700L (enExample)
NZ (1) NZ535430A (enExample)
PL (1) PL371620A1 (enExample)
PT (1) PT1496884E (enExample)
UA (1) UA79457C2 (enExample)
WO (1) WO2003084525A1 (enExample)
ZA (1) ZA200407593B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMP200800012B (it) * 2005-07-22 2008-02-27 Procter & Gamble Composizioni per ridurre l'incidenza di aritmia indotta da farmaco
CN103071154A (zh) 2007-04-13 2013-05-01 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
US7618955B2 (en) 2009-11-17
UA79457C2 (en) 2007-06-25
EP1496884A1 (fr) 2005-01-19
NZ535430A (en) 2006-09-29
CN1297265C (zh) 2007-01-31
FR2838057A1 (fr) 2003-10-10
BR0309019A (pt) 2005-02-01
MA27114A1 (fr) 2004-12-20
DK1496884T3 (da) 2006-10-02
EA006978B1 (ru) 2006-06-30
ATE329591T1 (de) 2006-07-15
CY1105106T1 (el) 2009-11-04
PL371620A1 (en) 2005-06-27
ES2264533T3 (es) 2007-01-01
EP1496884B1 (fr) 2006-06-14
EA200401293A1 (ru) 2005-02-24
AU2003246774A1 (en) 2003-10-20
MXPA04009760A (es) 2004-12-13
AR039253A1 (es) 2005-02-16
GEP20074101B (en) 2007-05-10
NO20044700L (no) 2004-10-29
HK1076034A1 (en) 2006-01-06
WO2003084525A1 (fr) 2003-10-16
ZA200407593B (en) 2006-07-26
AU2003246774B2 (en) 2007-02-15
PT1496884E (pt) 2006-09-29
JP2005528376A (ja) 2005-09-22
DE60306133T2 (de) 2007-01-04
US20050143354A1 (en) 2005-06-30
KR100645143B1 (ko) 2006-11-10
KR20040098053A (ko) 2004-11-18
DE60306133D1 (de) 2006-07-27
CN1646111A (zh) 2005-07-27
CA2480697A1 (fr) 2003-10-16
JP4065853B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
FR18C1023I2 (fr) Variants d'immunoglobuline et utilisations
EP1423399A4 (en) HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATIZING AGENTS
EP1456765A4 (en) PRIORITIES FOR ACCESSING THIRD PARTIES TO A COMMERCIAL ONLINE SITE
CY2014027I2 (el) Xρηση διαλκυλο φουμαρικων εστερων
EP1382199A4 (en) Personal video recorder systems and methods
ATE449766T1 (de) Piperazinyl- und diazapanylbenzamide und- benzothioamide
FR2864604B1 (fr) Raccord et partie d'un tel raccord
FR2838057B1 (fr) Nouvelle association d'un antithrombotique et d'aspirine
FR2849922B1 (fr) Support d'elements chromophores.
FR2849267B1 (fr) Fabrication d'un condensateur a capacite elevee
DE60039319D1 (de) Asphärische Ojektivlinse und Herstellungsverfahren derselben
EP1385945A4 (en) NEW MUTATION
EP1402892A4 (en) Antiinflammatoric and antitussive compositions
ITMI20020087A1 (it) Procedimento per l'avviamento di un filatoio ad anelli e filatoio ad anelli
ATE331956T1 (de) Nachweis von entzündungen
DE50301665D1 (de) Torblatthandgriff sowie Verwendung desselben
DE60207900D1 (de) "Suspend"-Paketübertrager
FR2843145B1 (fr) Marche d'escalier helicoidal
FR2822097B1 (fr) Robot d'inspection et d'intervention
ITVR20020108A1 (it) Impianto e procedimento per l'applicazione di un film
ITFI20010053U1 (it) Pomata idratante ad effetto peeling ed antirughe
ITMI20011196A0 (it) Derivato tetramerico dell'indol-3-carbinolo ad attivita' anticancerogena e metodo di sintesi del derivato stesso
ITMI20022678A1 (it) Negativoscopio con mezzi di mascheratura dell'area di
FR2825482B1 (fr) Horloge d'edifice
FR2805558B1 (fr) Ecran solaire et coupe-vent portable

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081231